返回ChemicalBook首页>CAS数据库列表>16506-27-7

16506-27-7

中文名称 宾达氮芥
英文名称 Bendamustine
CAS 16506-27-7
分子式 C16H21Cl2N3O2
分子量 358.26
MOL 文件 16506-27-7.mol
更新日期 2024/04/02 22:44:43
16506-27-7 结构式 16506-27-7 结构式

基本信息

中文别名
宾达氮芥
苯达莫司汀
4-[5-[双(2-氯乙基)氨基]-1-甲基苯并咪唑-2-基]丁酸
盐酸苯达莫司汀/4-[5-[双(2-氯乙基)氨基]-1-甲基苯并咪唑-2-基]丁酸
英文别名
Bendamustine
4-(5-(Bis(2-chloroethyl)
-1-methyl-1H-benzo[d]imidazol-2-yl)
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
1H-BenziMidazole-2-butanoicacid, 5-[bis(2-chloroethyl)aMino]-1-Methyl-
4-(5-(bis(2-chloroethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoic acid

物理化学性质

沸点585.2±50.0 °C(Predicted)
密度1.31±0.1 g/cm3(Predicted)
储存条件-20°C, protect from light
溶解度DMSO : 100 mg/mL (279.13 mM; Need ultrasonic)
酸度系数(pKa)4.50±0.10(Predicted)
宾达氮芥价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/04/30S5939宾达氮芥
Bendamustine
16506-27-75mg959.1元
2024/04/30S5939宾达氮芥
Bendamustine
16506-27-725mg3661.33元
2024/01/16S5939Bendamustine (SDX105)16506-27-710mM (1mL in DMSO)1122.03元

常见问题列表

生物活性
Bendamustine (SDX105)是一种氮芥药物,用于治疗慢性淋巴细胞白血病、多发性骨髓瘤和非霍奇金淋巴瘤。
靶点

DNA Alkylator/Crosslinker

体外研究

Bendamustine is a DNA cross-linking agent that causes DNA breaks, with alkylating and antimetabolite properties. Bendamustine uniquely regulates apoptosis pathways and DNA repair pathways in non-Hodgkin's lymphoma cells. Bendamustine (50 μM) induces p21 (Cip1/Waf1) and NOXA genes, and increases the expression of p53 in SU-DHL-1 cells. Bendamustine (25 μM) blocks mitotic checkpoints and cuases mitotic catastrophe.
Bendamustine reduces the viability of multiple myeloma (MM) cell lines, such as RPMI-8226 and 8226-LR5 cells, with IC 25 s of 101.8 μM and 585.5 μM after 24 h incubation, and 51.7 and 374.3 μM after 48 h incubation, respectively. Bendamustine induces a specific caspase-dependent MM cell death and inhibits the spindle-assembly checkpoint.

体内研究

Bendamustine (25 mg/kg, i.v.) shows potent inhibition on the growth of tumor cells by 91%, 99% and 95% for DoHH-2, Granta 519 and RAMOS models, respectively. Moreover, the antitumor effect of Bendamustine is enhanced by rituximab in DoHH-2 and RAMOS models, but not in Granta 519 model.

"16506-27-7" 相关产品信息
305-03-3 60-32-2 56-40-6 10094-34-5 56-12-2 119-36-8 77-86-1 51-17-2 154-93-8 143390-89-0 3543-75-7 13010-47-4 55-86-7 111-41-1 78-93-3 74-83-9